12:00 AM
 | 
Sep 03, 2012
 |  BC Week In Review  |  Company News  |  Deals

Par Pharmaceutical, TPG deal

Generics company Par said the "go shop" period for it to obtain an alternative acquisition proposal to investment firm TPG's bid of $50...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >